Booij J - Search Results

1

Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database.

Nobili F, Naseri M, De Carli F, Asenbaum S, Booij J, Darcourt J, Ell P, Kapucu O, Kemp P, Svarer C, Morbelli S, Pagani M, Sabri O, Tatsch K, Tossici-Bolt L, Sera T, Vander Borght T, Van Laere K, Varrone A. Nobili F, et al. Among authors: booij j. Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):565-73. doi: 10.1007/s00259-012-2304-8. Epub 2012 Dec 12. Eur J Nucl Med Mol Imaging. 2013. PMID: 23232506

2

Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease.

Booij J, Tissingh G, Winogrodzka A, Boer GJ, Stoof JC, Wolters EC, van Royen EA. Booij J, et al. Eur J Nucl Med. 1997 Jan;24(1):68-71. doi: 10.1007/BF01728311. Eur J Nucl Med. 1997. PMID: 9044880

3

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.

Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AG, Wolters EC, van Royen EA. Booij J, et al. J Neurol Neurosurg Psychiatry. 1997 Feb;62(2):133-40. doi: 10.1136/jnnp.62.2.133. J Neurol Neurosurg Psychiatry. 1997. PMID: 9048712 Free PMC article. Clinical Trial.

4

Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomography.

Booij J, Korn P, Linszen DH, van Royen EA. Booij J, et al. Eur J Nucl Med. 1997 Jun;24(6):674-7. doi: 10.1007/BF00841408. Eur J Nucl Med. 1997. PMID: 9169577 Clinical Trial.

5

[123I]beta-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls.

Tissingh G, Bergmans P, Booij J, Winogrodzka A, Stoof JC, Wolters EC, Van Royen EA. Tissingh G, et al. Among authors: booij j. Eur J Nucl Med. 1997 Sep;24(9):1171-4. doi: 10.1007/BF01254252. Eur J Nucl Med. 1997. PMID: 9283113

6

[123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys.

Booij J, Andringa G, Rijks LJ, Vermeulen RJ, De Bruin K, Boer GJ, Janssen AG, Van Royen EA. Booij J, et al. Synapse. 1997 Nov;27(3):183-90. doi: 10.1002/(SICI)1098-2396(199711)27:3<183::AID-SYN4>3.0.CO;2-9. Synapse. 1997. PMID: 9329154

7

Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters.

Booij J, Busemann Sokole E, Stabin MG, Janssen AG, de Bruin K, van Royen EA. Booij J, et al. Eur J Nucl Med. 1998 Jan;25(1):24-30. Eur J Nucl Med. 1998. PMID: 9396871 Clinical Trial.

8

Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.

Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, Stoof JC, Wolters EC. Tissingh G, et al. Among authors: booij j. J Nucl Med. 1998 Jul;39(7):1143-8. J Nucl Med. 1998. PMID: 9669384 Free article.

9

Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.

Booij J, Habraken JB, Bergmans P, Tissingh G, Winogrodzka A, Wolters EC, Janssen AG, Stoof JC, van Royen EA. Booij J, et al. J Nucl Med. 1998 Nov;39(11):1879-84. J Nucl Med. 1998. PMID: 9829575 Free article.

10

Iodine-123 labelled nor-beta-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in rats.

Booij J, Knol RJ, Reneman L, de Bruin K, Janssen AG, van Royen EA. Booij J, et al. Eur J Nucl Med. 1998 Dec;25(12):1666-9. doi: 10.1007/s002590050346. Eur J Nucl Med. 1998. PMID: 9871099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

397 results

Search Page

Filters